NCT04761614View on ClinicalTrials.gov

Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 2, 2021

Primary Completion Date

April 4, 2023

Study Completion Date

May 6, 2023

Conditions

Metastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8Stage IVB Colorectal Cancer AJCC v8Stage IVC Colorectal Cancer AJCC v8

Interventions

BIOLOGICAL

Bevacizumab

Given IVPB

DRUG

Fluorouracil

Given IV

DRUG

Leucovorin Calcium

Given IVPB

DRUG

Oxaliplatin

Given IVPB

DRUG

Riluzole

Given PO

Trial Locations (1)

43210

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors

lead

Ning Jin

OTHER

NCT04761614 - Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter